Pubblicazioni

Digital droplet PCR for T315I BCR::ABL1 KD mutation assessment in adult Ph-positive acute lymphoblastic leukemia with a minimal residual disease increase

2023 - LEUKEMIA & LYMPHOMA

Cardinali, D.; Beldinanzi, M.; Ansuinelli, M.; Elia, L.; Della Starza, I.; Bellomarino, V.; Matarazzo, M.; Di Trani, M.; Cola, M.; Salutari, P.; Cedrone, M.; Bassan, R.; De Gobbi, M.; Della Porta, M. G.; De Simone, M.; Alati, C.; Fracchiolla, N. S.; Lunghi, M.; Intermesoli, T.; Cardinali, V.; MulÃ¨, A.; Guarini, A.; FoÃ , R.; Chiaretti, S.

Donor cell derived mantle cell lymphoma in a HSCT sibling donor-recipient pair: intrinsic biological clock in lymphomagenesis

2022 - LEUKEMIA & LYMPHOMA

Musiu, P.; Quattrocchi, L.; Barberi, W.; Della Starza, I.; Elia, L.; De Novi, L. A.; Petrucci, L.; De Luca, G.; Di Rocco, A.; La Rocca, U.

ZNF384 rearrangement is the most frequent genetic lesion in adult PH-negative and Ph-like-negative B-other acute lymphoblastic leukemia. Biological and clinical findings

2022 - LEUKEMIA & LYMPHOMA

Chiaretti, Sabina; Taherinasab, Akram; Della Starza, Irene; Canichella, Martina; Ansuinelli, Michela; De Propris, Maria Stefania; Messina, Monica; Spinelli, Orietta; Santoro, Alessandra; De Novi, Lucia Anna; Cardinali, Deborah; Schipani, Mattia; Arena, Valentina; Bassan, Renato; Guarini, Anna; FoÃ , Robin

New dead/H-Box helicase gene (Ddx41) mutation in an italian family with recurrent leukemia.

2021 - LEUKEMIA & LYMPHOMA

Fazio, F.; Quintini, M.; Carmosino, I.; Matteucci, C.; Miulli, E.; Pellanera, F.; Lucani, B.; Ansuinelli, M.; Breccia, M.; Mecucci, C.; Latagliata, R.

Ponatinib for the treatment of Ph-like acute lymphoblastic leukemia

2021 - LEUKEMIA & LYMPHOMA

Lunghi, M.; Patriarca, A.; Greco, M.; Taherinasab, A.; Della Starza, I.; Cavalli, M.; Gaidano, G.; Foa, R.; Chiaretti, S.

Real-life evaluation of potential candidates for treatment discontinuation in chronic myeloid leukemia: the impact of age and long-term follow-up

2021 - LEUKEMIA & LYMPHOMA

Scalzulli, Emilia; Colafigli, Gioia; Pepe, Sara; DE LUCA, Giulia; DI PRIMA, Alessio; Efficace, Fabio; Diverio, Daniela; Latagliata, Roberto; Martelli, Maurizio; Robin, FoÃ ; Breccia, Massimo

Smoothened inhibitor erismodegib combined with nilotinib in patients with chronic myeloid leukemia resistant/intolerant to at least one prior tyrosine kinase inhibitor: a phase 1b study

2021 - LEUKEMIA & LYMPHOMA

Ottmann Oliver, G.; Stegelmann, Frank; Breccia, Massimo; Steegmann Juan, Luis; Olavarria, Eduardo; Aimone, Paola; Lipton Jeffrey, H.

Very late acute myeloid leukemia relapse: clinical features, treatment and outcome

2021 - LEUKEMIA & LYMPHOMA

Mariani, Sabrina; Trisolini, Silvia Maria; Minotti, Clara; Breccia, Massimo; Cartoni, Claudio; De Propris, Maria Stefania; Loglisci, Giovanna; Latagliata, Roberto; Limongi, Maria Zaira; Testi, Anna Maria; Foa, Robin; Capria, Saveria

Peripherally inserted central catheter in patients with acute myeloid leukemia. Incidence and risk factors for premature removal

2020 - LEUKEMIA & LYMPHOMA

Bruzzese, A.; Chistolini, A.; Morano, S. G.; Alunni Fegatelli, D.; Micozzi, A.

IL7R overexpression in adult acute lymphoblastic leukemia is associated to JAK/STAT pathway mutations and identifies patients who could benefit from targeted therapies

2018 - LEUKEMIA & LYMPHOMA

Gianfelici, V; Messina, M; Paoloni, F; Peragine, N; Lauretti, A; Fedullo, Al; Di Giacomo, F; Vignetti, M; Vitale, A; Guarini, A; Chiaretti, S; FoÃ , R.